Eisemann T - Search Results

1

αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.

de Groot JS, Ratze MA, van Amersfoort M, Eisemann T, Vlug EJ, Niklaas MT, Chin SF, Caldas C, van Diest PJ, Jonkers J, de Rooij J, Derksen PW. de Groot JS, et al. Among authors: eisemann t. J Pathol. 2018 Aug;245(4):456-467. doi: 10.1002/path.5099. Epub 2018 Jun 20. J Pathol. 2018. PMID: 29774524 Free PMC article.

2

Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.

Krieger TG, Tirier SM, Park J, Jechow K, Eisemann T, Peterziel H, Angel P, Eils R, Conrad C. Krieger TG, et al. Among authors: eisemann t. Neuro Oncol. 2020 Aug 17;22(8):1138-1149. doi: 10.1093/neuonc/noaa091. Neuro Oncol. 2020. PMID: 32297954 Free PMC article.

3

An advanced glioma cell invasion assay based on organotypic brain slice cultures.

Eisemann T, Costa B, Strelau J, Mittelbronn M, Angel P, Peterziel H. Eisemann T, et al. BMC Cancer. 2018 Jan 30;18(1):103. doi: 10.1186/s12885-018-4007-4. BMC Cancer. 2018. PMID: 29378533 Free PMC article.

4

Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.

Eisemann T, Costa B, Harter PN, Wick W, Mittelbronn M, Angel P, Peterziel H. Eisemann T, et al. Neuro Oncol. 2019 Feb 19;21(3):326-336. doi: 10.1093/neuonc/noy184. Neuro Oncol. 2019. PMID: 30418623 Free PMC article.

5

Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells.

Costa B, Eisemann T, Strelau J, Spaan I, Korshunov A, Liu HK, Bugert P, Angel P, Peterziel H. Costa B, et al. Among authors: eisemann t. Blood Adv. 2019 Apr 9;3(7):1092-1102. doi: 10.1182/bloodadvances.2018015966. Blood Adv. 2019. PMID: 30948364 Free PMC article.

6

Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression.

Eisemann T, Costa B, Peterziel H, Angel P. Eisemann T, et al. Front Oncol. 2019 Mar 26;9:187. doi: 10.3389/fonc.2019.00187. eCollection 2019. Front Oncol. 2019. PMID: 30972297 Free PMC article.

7

CD44 expressed by myeloid cells promotes glioma invasion.

Ivanova EL, Costa B, Eisemann T, Lohr S, Boskovic P, Eichwald V, Meckler J, Jugold M, Orian-Rousseau V, Peterziel H, Angel P. Ivanova EL, et al. Among authors: eisemann t. Front Oncol. 2022 Aug 4;12:969787. doi: 10.3389/fonc.2022.969787. eCollection 2022. Front Oncol. 2022. PMID: 35992852 Free PMC article.

8

A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors.

Costa B, Fletcher MNC, Boskovic P, Ivanova EL, Eisemann T, Lohr S, Bunse L, Löwer M, Burchard S, Korshunov A, Coltella N, Cusimano M, Naldini L, Liu HK, Platten M, Radlwimmer B, Angel P, Peterziel H. Costa B, et al. Among authors: eisemann t. Cancers (Basel). 2021 Jan 10;13(2):230. doi: 10.3390/cancers13020230. Cancers (Basel). 2021. PMID: 33435218 Free PMC article.

9

Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.

Eisemann T, Wechsler-Reya RJ. Eisemann T, et al. Genes Dev. 2022 May 1;36(9-10):514-532. doi: 10.1101/gad.349538.122. Genes Dev. 2022. PMID: 35680424 Free PMC article. Review.

10

Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.

Kang KD, Bernstock JD, Totsch SK, Gary SE, Rocco A, Nan L, Li R, Etminan T, Han X, Beierle EA, Eisemann T, Wechsler-Reya RJ, Bae S, Whitley R, Gillespie GY, Markert JM, Friedman GK. Kang KD, et al. Among authors: eisemann t. Clin Cancer Res. 2022 Dec 15;28(24):5419-5430. doi: 10.1158/1078-0432.CCR-22-1382. Clin Cancer Res. 2022. PMID: 36239623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page